The Catalyst Pharmaceuticals Inc. outperforms the competitors on a strong trading day

by

Shares of Catalyst Pharmaceuticals Inc. CPRX,
+ 0.70%
fell 0.70% higher to $ 4.31 Thursday, on what turned out to be an all-round grim trading session for the stock market, with the NASDAQ Composite Index COMP,
-0.72%
down 0.72% to 13,865.36 and Dow Jones Industrial Average DJIA,
-0.38%
decreased by 0.38% to 31,493.34. This was the stock’s second consecutive day of profit. Catalyst Pharmaceuticals Inc. closed down $ 0.97 from its 52-week high ($ 5.28), which the company hit on Feb. 20.

The stock outperformed some of its competitors on Thursday, such as Johnson & Johnson JNJ,
+ 0.05%
rose 0.05% to $ 165.74, Pfizer Inc. PFE,
-0.95%
decreased 0.95% to $ 34.56, and Abbott Laboratories ABT,
-1.44%
fell 1.44% to $ 125.41. The trade volume (1.6 million) remained 394,618 below the 50-day average volume of 2.0 million.

Editor’s Note: This story was automatically generated by Automated Insights using data from Dow Jones and FactSet. See our terms of use for market data.

Source